Status:
UNKNOWN
Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy
Lead Sponsor:
Inonu University
Conditions:
Depressive Disorder
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The investigators evaluate the effects of a subanesthetic dose of ketamine, administered as an adjunct to sevoflurane, on duration of seizure activity, hemodynamic profile and recovery times during el...
Detailed Description
Patients will randomly allocate, to either a sevoflurane-ketamine (Group SK), sevoflurane-saline (Group SS) receiving group. Mean arterial pressure (MAP) and heart rate (HR) will record prior to anest...
Eligibility Criteria
Inclusion
- Major depressive patients
Exclusion
- Pregnancy
- Have a history of myocardial infarction in the previous six months
- Atrial fibrillation or flutter
- Heart block
- Unregulated hypertension
- Cerebrovascular diseases
- A known drug allergy
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02267980
Start Date
July 1 2014
End Date
October 1 2014
Last Update
October 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turgut Ozal Medical Center
Malatya, Turkey (Türkiye), 44315